Skip to content
  • Sunday, 26 July 2026
  • 3:40 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch
Pharmaceutical R&D

SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch

Teuku Ryan Jun 17, 2026 0

The biotech firm SpliSense is making significant strides in the development of a novel therapy for cystic fibrosis, announcing a…

Read More
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Myelin Damage and Brain Deterioration in UConn Study

Rifan Muazin Jun 4, 2026 0

A pharmaceutical combination that has become a cornerstone of modern anti-aging and longevity research may pose a severe risk to…

Read More
Pharmaceutical R&D

Lilly’s $7bn Acquisition of Kelonia Bears Fruit as In Vivo Cell Therapies Show Significant Promise at ASCO 2026

Teuku Ryan Jun 3, 2026 0

The American Society for Clinical Oncology (ASCO) meeting in 2026, a cornerstone event for oncological advancements, has concluded, leaving behind…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Study Reveals Significant Heart Tissue Weakening and Arrhythmia Risk in Low Gravity Environments

Dwi Wanna Jun 2, 2026 0

In a landmark study that underscores the biological challenges of long-duration space exploration, scientists at Johns Hopkins Medicine have found…

Read More
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Brain Damage and Myelin Loss in New Study

Rifan Muazin May 27, 2026 0

A drug combination that has become a cornerstone of modern longevity research may carry unforeseen and devastating consequences for neurological…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations

Teuku Ryan May 27, 2026 0

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…

Read More
Pharmaceutical R&D

Datroway Receives FDA Approval for Metastatic Triple-Negative Breast Cancer, Marking a Significant Advancement in Targeted Therapy

Teuku Ryan May 25, 2026 0

The US Food and Drug Administration (FDA) has granted a pivotal approval for Datroway (datopotamab deruxtecan), a novel antibody-drug conjugate…

Read More
Neuroscience & Brain Research

UC Davis Health Study Reveals Significant Choline Deficiencies in the Brains of Individuals with Anxiety Disorders

Rifan Muazin May 16, 2026 0

A groundbreaking meta-analysis led by researchers at UC Davis Health has identified a consistent chemical signature in the brains of…

Read More
Neuroscience & Brain Research

Lifelong Mental Stimulation Linked to Significant Delay in Alzheimer’s Disease Onset and Slower Cognitive Decline

Rifan Muazin May 16, 2026 0

Engaging in a consistent regimen of mentally stimulating activities throughout one’s life, such as reading, writing, and the acquisition of…

Read More
Neuroscience & Brain Research

University of Toronto Study Reveals Mental Sharpness Fluctuations Account for Significant Daily Productivity Gaps

Rifan Muazin May 15, 2026 0

The University of Toronto Scarborough has released a comprehensive study detailing how fluctuations in daily mental sharpness serve as a…

Read More

Posts pagination

1 2 3 4
The Subtle Art of Cellular Division: How Different Failures Lead to Drastically Different OutcomesWegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key MarketsRecent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery HopesScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ